Progression of Metastatic Pancreatic Cancer

5 Pogledi
administrator
administrator
07/30/23

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći